Delivery Order SPE2DB20D1050-SPE2DB24FH31L
Award Date 10/11/23
Potential Completion Date 10/12/23
Potential Value $2.7K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) for the delivery of Ondansetron ODT 4 mg tablets. The firm-fixed-price delivery order, valued at $2,446.96, has an ultimate completion date of January 26, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,856.01 firm fixed-price delivery order is for the supply of Ondansetron ODT 4 mg tablets, a medication primarily used to prevent nausea and vomiting. The award has an ultimate completion date of May 22, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA). The $16,790.43 firm-fixed-price delivery order is for Ondansetron HCL 8 mg tablets, a medication used to prevent nausea and vomiting. The award has an ultimate completion date of March 1, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award, valued at $10,806.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ondansetron ODT 4 MG Tablets in quantities of 30. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 28, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $3,677.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4563217759 units of Ondansetron ODT 4 mg tablets, which are used to treat nausea and vomiting. This is a firm-fixed-price delivery order contract with a completion date of January 4, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,002.04 delivery order is for the supply of 4 mg Ondansetron orally disintegrating tablets, which are used to prevent nausea and vomiting. The contract has a firm fixed price and is set to be completed by May 15, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery...
- This federal contract award, valued at $1,463.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,490,062 units of Ondansetron ODT 4 MG Tablet 30S, a medication used to treat nausea and vomiting. The award has an ultimate completion date of January 31, 2024 and is a Firm Fixed Price Delivery Order contract. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- This federal contract award, with an ID of SPE2DB22D3011 and SPE2DB24FP9RN, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,065.53 firm-fixed-price delivery order is for the provision of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of March 7, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,894.54 firm fixed-price delivery order is for the supply of 4,564,247,355 units of Ondansetron ODT 4 MG Tablets. The contract has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,940.22 firm fixed-price delivery order is for the supply of 4 mg Ondansetron ODT tablets, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of March 4, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...